PE20061080A1 - Compuestos derivados de piridotienopirimidina como inhibidores de fosfodiesterasa 4 - Google Patents
Compuestos derivados de piridotienopirimidina como inhibidores de fosfodiesterasa 4Info
- Publication number
- PE20061080A1 PE20061080A1 PE2005001378A PE2005001378A PE20061080A1 PE 20061080 A1 PE20061080 A1 PE 20061080A1 PE 2005001378 A PE2005001378 A PE 2005001378A PE 2005001378 A PE2005001378 A PE 2005001378A PE 20061080 A1 PE20061080 A1 PE 20061080A1
- Authority
- PE
- Peru
- Prior art keywords
- pyrane
- morpholin
- pyrimidin
- dihydro
- dimethyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- MSYGAHOHLUJIKV-UHFFFAOYSA-N 3,5-dimethyl-1-(3-nitrophenyl)-1h-pyrazole-4-carboxylic acid ethyl ester Chemical compound CC1=C(C(=O)OCC)C(C)=NN1C1=CC=CC([N+]([O-])=O)=C1 MSYGAHOHLUJIKV-UHFFFAOYSA-N 0.000 title abstract 2
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 title abstract 2
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE R1 Y R2 SON H O ALQUILO(C1-C4); n ES 0 O 1; R3 ES ALQUILO(C1-C20), ARILO(C5-C14) MONOCICLICO O POLICICLICO, HETEROARILO DE 5 A 14 MIEMBROS QUE COMPRENDE AL MENOS UN ANILLO HETEROAROMATICO Y QUE CONTIENE UN HETEROATOMO SELECCIONADO DE O, S O N, OPCIONALMENTE SUSTITUIDOS CON HALOGENO, CF3, SO2NH2, ENTRE OTROS; R4 Y R5 SON H, ALQUILO(C1-C20), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 2,2-DIMETIL-5-MORFOLIN-4-IL-N-(2-FENETILETIL)-1,4-DIHIDRO-2H-PIRANO[4",3":4',5']PIRIDO[3',2':4,5]TIENO[3,2-d]PIRIMIDIN-8-AMINA, 2,2-DIMETIL-5-MORFOLIN-4-IL-N-(4-METILPIPERIDIN-1-IL)-1,4-DIHIDRO-2H-PIRANO[4",3":4',5']PIRIDO[3',2':4,5]TIENO[3,2-d]PIRIMIDIN-8-AMINA, 2,2-DIMETIL-5-MORFOLIN-4-IL-N-(2-DIETILAMINOETIL)-1,4-DIHIDRO-2H-PIRANO[4",3":4',5']PIRIDO[3',2':4,5]TIENO[3,2-d]PIRIMIDIN-8-AMINA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE LA FOSFODIESTERASA 4 SIENDO UTILES EN EL TRATAMIENTO DE ASMA, ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA, ARTRITIS REUMATOIDE, PSORIASIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200402877A ES2259892B1 (es) | 2004-11-30 | 2004-11-30 | Nuevos derivados de piridotienopirimidina. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061080A1 true PE20061080A1 (es) | 2006-11-10 |
Family
ID=35064809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001378A PE20061080A1 (es) | 2004-11-30 | 2005-11-28 | Compuestos derivados de piridotienopirimidina como inhibidores de fosfodiesterasa 4 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20080207645A1 (es) |
| EP (1) | EP1819712A1 (es) |
| JP (1) | JP2008521854A (es) |
| KR (1) | KR20070086652A (es) |
| CN (1) | CN101068817A (es) |
| AR (1) | AR052413A1 (es) |
| AU (1) | AU2005311422A1 (es) |
| BR (1) | BRPI0518117A (es) |
| CA (1) | CA2588808A1 (es) |
| ES (1) | ES2259892B1 (es) |
| IL (1) | IL183141A0 (es) |
| MX (1) | MX2007006172A (es) |
| NO (1) | NO20073271L (es) |
| PE (1) | PE20061080A1 (es) |
| RU (1) | RU2007124493A (es) |
| TW (1) | TW200631954A (es) |
| UY (1) | UY29240A1 (es) |
| WO (1) | WO2006058723A1 (es) |
| ZA (1) | ZA200703700B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2281251B1 (es) * | 2005-07-27 | 2008-08-16 | Laboratorios Almirall S.A. | Nuevos derivados de pirido (3',2':4,5) furo (3,2-d) pirimidina. |
| WO2012131297A1 (en) | 2011-03-28 | 2012-10-04 | Jonathan Bayldon Baell | Pyrido [3',2' :4,5] thieno [3, 2-d] pyrimidin- 4 - ylamine derivatives and their therapeutical use |
| KR20140127218A (ko) | 2011-12-21 | 2014-11-03 | 인비스타 테크놀러지스 에스.에이 알.엘. | 안정한 에멀젼을 감소시키기 위한 추출 용매 제어 |
| CN103242276B (zh) * | 2013-05-07 | 2014-07-16 | 白银安杰利生化科技有限公司 | 2,2-二甲基四氢-2h-吡喃-4-羧酸的合成方法 |
| BR112018003417B1 (pt) | 2016-06-22 | 2023-10-24 | Vanderbilt University | Composto modulador alostérico positivo do receptor muscarínico de acetilcolina m4 e composição farmacêutica que o compreende |
| ES2892956T3 (es) | 2016-11-07 | 2022-02-07 | Univ Vanderbilt | Moduladores alostéricos positivos del receptor muscarínico de acetilcolina M4 |
| EP3558309B1 (en) | 2016-11-07 | 2023-07-26 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| MA46722A (fr) | 2016-11-07 | 2019-09-11 | Univ Vanderbilt | Modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4 |
| TW201930311A (zh) | 2017-12-05 | 2019-08-01 | 泛德比爾特大學 | 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑 |
| CN111406058A (zh) | 2017-12-05 | 2020-07-10 | 范德比尔特大学 | 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19644228A1 (de) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine |
| DE19752952A1 (de) * | 1997-11-28 | 1999-06-02 | Merck Patent Gmbh | Thienopyrimidine |
| DE19819023A1 (de) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
| WO2000059912A1 (en) * | 1999-03-30 | 2000-10-12 | Nippon Soda Co., Ltd. | Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
-
2004
- 2004-11-30 ES ES200402877A patent/ES2259892B1/es not_active Expired - Fee Related
-
2005
- 2005-11-28 AR ARP050104957A patent/AR052413A1/es unknown
- 2005-11-28 PE PE2005001378A patent/PE20061080A1/es not_active Application Discontinuation
- 2005-11-29 UY UY29240A patent/UY29240A1/es unknown
- 2005-11-30 EP EP05813317A patent/EP1819712A1/en not_active Withdrawn
- 2005-11-30 RU RU2007124493/04A patent/RU2007124493A/ru not_active Application Discontinuation
- 2005-11-30 US US11/791,451 patent/US20080207645A1/en not_active Abandoned
- 2005-11-30 AU AU2005311422A patent/AU2005311422A1/en not_active Abandoned
- 2005-11-30 WO PCT/EP2005/012773 patent/WO2006058723A1/en not_active Ceased
- 2005-11-30 BR BRPI0518117-8A patent/BRPI0518117A/pt not_active IP Right Cessation
- 2005-11-30 JP JP2007543766A patent/JP2008521854A/ja active Pending
- 2005-11-30 KR KR1020077014496A patent/KR20070086652A/ko not_active Withdrawn
- 2005-11-30 CA CA002588808A patent/CA2588808A1/en not_active Abandoned
- 2005-11-30 TW TW094142174A patent/TW200631954A/zh unknown
- 2005-11-30 MX MX2007006172A patent/MX2007006172A/es not_active Application Discontinuation
- 2005-11-30 CN CNA2005800409703A patent/CN101068817A/zh active Pending
-
2007
- 2007-05-08 ZA ZA200703700A patent/ZA200703700B/en unknown
- 2007-05-10 IL IL183141A patent/IL183141A0/en unknown
- 2007-06-26 NO NO20073271A patent/NO20073271L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR052413A1 (es) | 2007-03-21 |
| US20080207645A1 (en) | 2008-08-28 |
| EP1819712A1 (en) | 2007-08-22 |
| ES2259892B1 (es) | 2007-11-01 |
| JP2008521854A (ja) | 2008-06-26 |
| AU2005311422A1 (en) | 2006-06-08 |
| CA2588808A1 (en) | 2006-06-08 |
| KR20070086652A (ko) | 2007-08-27 |
| UY29240A1 (es) | 2006-02-24 |
| CN101068817A (zh) | 2007-11-07 |
| TW200631954A (en) | 2006-09-16 |
| WO2006058723A1 (en) | 2006-06-08 |
| ZA200703700B (en) | 2008-07-30 |
| MX2007006172A (es) | 2007-07-13 |
| BRPI0518117A (pt) | 2008-11-04 |
| WO2006058723A8 (en) | 2007-07-12 |
| ES2259892A1 (es) | 2006-10-16 |
| IL183141A0 (en) | 2007-09-20 |
| NO20073271L (no) | 2007-06-26 |
| RU2007124493A (ru) | 2009-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
| CL2004000917A1 (es) | Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa | |
| TW200602338A (en) | Selected CGRP antagonists, process for preparing them and their use as pharmaceutical compositions | |
| BR0308056A (pt) | Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto | |
| NO20051694L (no) | Heterosykliske forbindelser | |
| DK1678166T3 (da) | Proteinkinaseinhibitorer | |
| WO2008045393A3 (en) | Imidazo- and triazolo-pyridine compounds and methods of use therof | |
| HUP0400246A2 (hu) | 1,2,4-Trioxolánt tartalmazó maláriaellenes gyógyszerkészítmények és eljárás az előállításukra és az alkalmazásukra | |
| MA29649B1 (fr) | Nouveaux derives de 2,4- dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk | |
| ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| BR0214809A (pt) | Compostos de pirimidina | |
| PE20060479A1 (es) | Compuestos heteroaril-aril-ureas como inhibidores de la quinasa | |
| ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
| MX2009010503A (es) | Compuestos heterociclicos antiviricos. | |
| DK1814846T3 (da) | 11beta-HSD1-inhibitorer | |
| MX2009009384A (es) | Malonamidas como antagonistas de orexina. | |
| TW200738682A (en) | Isoquinoline derivatives | |
| UA98966C2 (ru) | Производные бензазепина, пригодные для использования в качестве антагонистов вазопрессина | |
| PE20080038A1 (es) | Derivados de tiazolidinadiona como inhibidores de la pi3 quinasa | |
| TN2010000173A1 (fr) | Antagonistes de cgrp | |
| TW200606151A (en) | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | |
| WO2009010789A3 (en) | Pyrimidine derivatives 934 | |
| TW200519096A (en) | Quinazoline analogs as receptor tyrosine kinase inhibitors | |
| PL1620425T3 (pl) | Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu | |
| ATE435223T1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |